Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1973 1
1974 1
1975 3
1985 2
1987 1
1993 1
1998 1
1999 5
2000 1
2002 1
2003 3
2006 3
2007 4
2008 5
2009 3
2010 5
2011 4
2012 8
2013 10
2014 7
2015 11
2016 18
2017 6
2018 8
2019 12
2020 14
2021 15
2022 20
2023 17
2024 20

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

183 results

Results by year

Filters applied: . Clear all
Page 1
Efficacy and safety of sparsentan versus irbesartan in patients with IgA nephropathy (PROTECT): 2-year results from a randomised, active-controlled, phase 3 trial.
Rovin BH, Barratt J, Heerspink HJL, Alpers CE, Bieler S, Chae DW, Diva UA, Floege J, Gesualdo L, Inrig JK, Kohan DE, Komers R, Kooienga LA, Lafayette R, Maes B, Małecki R, Mercer A, Noronha IL, Oh SW, Peh CA, Praga M, Preciado P, Radhakrishnan J, Rheault MN, Rote WE, Tang SCW, Tesar V, Trachtman H, Trimarchi H, Tumlin JA, Wong MG, Perkovic V; DUPRO steering committee and PROTECT Investigators. Rovin BH, et al. Lancet. 2023 Dec 2;402(10417):2077-2090. doi: 10.1016/S0140-6736(23)02302-4. Epub 2023 Nov 3. Lancet. 2023. PMID: 37931634 Clinical Trial.
Sparsentan in patients with IgA nephropathy: a prespecified interim analysis from a randomised, double-blind, active-controlled clinical trial.
Heerspink HJL, Radhakrishnan J, Alpers CE, Barratt J, Bieler S, Diva U, Inrig J, Komers R, Mercer A, Noronha IL, Rheault MN, Rote W, Rovin B, Trachtman H, Trimarchi H, Wong MG, Perkovic V; PROTECT Investigators. Heerspink HJL, et al. Lancet. 2023 May 13;401(10388):1584-1594. doi: 10.1016/S0140-6736(23)00569-X. Epub 2023 Apr 1. Lancet. 2023. PMID: 37015244 Clinical Trial.
Worldwide access to treatment for end-stage kidney disease: a systematic review.
Liyanage T, Ninomiya T, Jha V, Neal B, Patrice HM, Okpechi I, Zhao MH, Lv J, Garg AX, Knight J, Rodgers A, Gallagher M, Kotwal S, Cass A, Perkovic V. Liyanage T, et al. Among authors: kotwal s. Lancet. 2015 May 16;385(9981):1975-82. doi: 10.1016/S0140-6736(14)61601-9. Epub 2015 Mar 13. Lancet. 2015. PMID: 25777665 Review.
Effect of Robot-Assisted Radical Cystectomy With Intracorporeal Urinary Diversion vs Open Radical Cystectomy on 90-Day Morbidity and Mortality Among Patients With Bladder Cancer: A Randomized Clinical Trial.
Catto JWF, Khetrapal P, Ricciardi F, Ambler G, Williams NR, Al-Hammouri T, Khan MS, Thurairaja R, Nair R, Feber A, Dixon S, Nathan S, Briggs T, Sridhar A, Ahmad I, Bhatt J, Charlesworth P, Blick C, Cumberbatch MG, Hussain SA, Kotwal S, Koupparis A, McGrath J, Noon AP, Rowe E, Vasdev N, Hanchanale V, Hagan D, Brew-Graves C, Kelly JD; iROC Study Team. Catto JWF, et al. Among authors: kotwal s. JAMA. 2022 Jun 7;327(21):2092-2103. doi: 10.1001/jama.2022.7393. JAMA. 2022. PMID: 35569079 Free PMC article. Clinical Trial.
Diagnostic Errors in the Emergency Department: A Systematic Review [Internet].
Newman-Toker DE, Peterson SM, Badihian S, Hassoon A, Nassery N, Parizadeh D, Wilson LM, Jia Y, Omron R, Tharmarajah S, Guerin L, Bastani PB, Fracica EA, Kotwal S, Robinson KA. Newman-Toker DE, et al. Among authors: kotwal s. Rockville (MD): Agency for Healthcare Research and Quality (US); 2022 Dec. Report No.: 22(23)-EHC043. Rockville (MD): Agency for Healthcare Research and Quality (US); 2022 Dec. Report No.: 22(23)-EHC043. PMID: 36574484 Free Books & Documents. Review.
Outcomes after Angiography with Sodium Bicarbonate and Acetylcysteine.
Weisbord SD, Gallagher M, Jneid H, Garcia S, Cass A, Thwin SS, Conner TA, Chertow GM, Bhatt DL, Shunk K, Parikh CR, McFalls EO, Brophy M, Ferguson R, Wu H, Androsenko M, Myles J, Kaufman J, Palevsky PM; PRESERVE Trial Group. Weisbord SD, et al. N Engl J Med. 2018 Feb 15;378(7):603-614. doi: 10.1056/NEJMoa1710933. Epub 2017 Nov 12. N Engl J Med. 2018. PMID: 29130810 Free article. Clinical Trial.
Immobilized invertase.
Kotwal SM, Shankar V. Kotwal SM, et al. Biotechnol Adv. 2009 Jul-Aug;27(4):311-22. doi: 10.1016/j.biotechadv.2009.01.009. Biotechnol Adv. 2009. PMID: 19472508 Review.
Barriers to Care: New Medications and CKD.
Kim D, Perkovic V, Kotwal S. Kim D, et al. Among authors: kotwal s. Kidney Int Rep. 2023 Dec 16;9(3):504-507. doi: 10.1016/j.ekir.2023.12.012. eCollection 2024 Mar. Kidney Int Rep. 2023. PMID: 38481511 Free PMC article. No abstract available.
Global Dialysis Perspective: Fiji.
Talbot B; Fijian Dialysis Registry Collaboration. Talbot B, et al. Kidney360. 2021 Oct 26;3(1):164-167. doi: 10.34067/KID.0005652021. eCollection 2022 Jan 27. Kidney360. 2021. PMID: 35368567 Free PMC article. No abstract available.
183 results